Funder: Jerome Lejeune Foundation
Due Dates: July 1, 2025 – September 5, 2025 (Autumn Call)
Funding Amounts: Pilot grants: up to €50,000 over 2 years | Advanced grants: up to €80,000 over 2 years
Summary: Supports innovative research on Trisomy 21, including fundamental, translational, clinical, epidemiological, and neuropsychological studies.
Key Information: Use of human embryonic/fetal tissues or materials from abortion, IVF, or cloning is strictly prohibited.